The SURMOUNT-4 trial (Aronne 2023, JAMA) showed that adults who stopped tirzepatide after 36 weeks regained an average of 14.0% of body weight over the next 52 weeks, while those who continued tirzepatide lost an additional 5.5% a 19.4% between-group difference
To achieve this, cells were fixed with 4% paraformaldehyde (P0099-100ml, Beyotime, Shanghai, China), permeabilized, stained with 0.1% crystal violet (G1064, Solarbio, Beijing, China), and measured using a plate reader (Molecular Devices) through spectrophotometry after the cells were dissolved with 10% acetic acid (A298827-500ml, Aladdin, Shanghai, China)
Retatrutide is not yet approved by any regulatory agency, meaning it is only available through research chemical suppliers
Fortunately, there are some life changes you can make to help with hormonal bloating throughout your cycle
Individuals with NF1, those with prior radiation therapy, and adults between ages 20 and 50 are at increased risk